General Information of the Compound
| Compound ID |
CP0893511
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-(2-(2,4-dioxo-1-(2-oxo-2-pyrrolidin-1-yl-ethyl)-5-phenyl-1,2,4,5-tetrahydro-1,3,5-benzotriazepin-3-yl)-acetylamino)-benzoic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C29H27N5O6
|
||||||||||||||||||
| Molecular Weight |
541.564
|
||||||||||||||||||
| Canonical SMILES |
O=C(CN1C(=O)N(CC(=O)N2CCCC2)c2ccccc2N(c2ccccc2)C1=O)Nc1cccc(C(=O)O)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C29H27N5O6/c35-25(30-21-10-8-9-20(17-21)27(37)38)18-33-28(39)32(19-26(36)31-15-6-7-16-31)23-13-4-5-14-24(23)34(29(33)40)22-11-2-1-3-12-22/h1-5,8-14,17H,6-7,15-16,18-19H2,(H,30,35)(H,37,38)
Show/Hide
|
||||||||||||||||||
| InChIKey |
SMBUONWXTIILJK-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00958, Cholecystokinin receptor type A
Protein ID: PT01124, Gastrin/cholecystokinin type B receptor